COL1A1 and osteogenesis imperfecta: COL1A1 expression was significantly increased in osteoblasts from the respective type IV OI patient vs. the more severe type III patient at Day 14 (p = 0.015) and 21 (p = 0.0001) for the patient pair with G352S substitutions.